Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel approaches for vaccine development
Makda S. Gebre, Luis A. Brito, Lisa H. Tostanoski, et al.
Cell (2021) Vol. 184, Iss. 6, pp. 1589-1603
Open Access | Times Cited: 244

Showing 26-50 of 244 citing articles:

Advances of mRNA vaccine in tumor: a maze of opportunities and challenges
Yuan Yuan, Fan Gao, Ying Chang, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 40
Emerging Trends in Lipid-Based Vaccine Delivery: A Special Focus on Developmental Strategies, Fabrication Methods, and Applications
Bharathi Karunakaran, Raghav Gupta, Pranav Patel, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 661-661
Open Access | Times Cited: 38
Components, Formulations, Deliveries, and Combinations of Tumor Vaccines
Tengfei Liu, Wenyan Yao, Wenyu Sun, et al.
ACS Nano (2024) Vol. 18, Iss. 29, pp. 18801-18833
Closed Access | Times Cited: 16
Engineering customized nanovaccines for enhanced cancer immunotherapy
JinYu Guo, Changhua Liu, Zhaoyang Qi, et al.
Bioactive Materials (2024) Vol. 36, pp. 330-357
Open Access | Times Cited: 14
Exosome may be the next generation of promising cell-free vaccines
Zelan Dai, Ruiru Cai, Hong Zeng, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 13
COVID-19 vaccines: Immune correlates and clinical outcomes
Shant H. Mahrokhian, Lisa H. Tostanoski, Samuel J. Vidal, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 12
mRNA Vaccine Nanoplatforms and Innate Immunity
Lai Wei, Chunhong Dong, Wandi Zhu, et al.
Viruses (2024) Vol. 16, Iss. 1, pp. 120-120
Open Access | Times Cited: 11
Advanced technologies for the development of infectious disease vaccines
Akash Gupta, Arnab Rudra, Kaelan Reed, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 12, pp. 914-938
Closed Access | Times Cited: 11
In silico designed novel multi-epitope mRNA vaccines against Brucella by targeting extracellular protein BtuB and LptD
Juan Shi, Yuejie Zhu, Zhengwei Yin, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Vaccine design and development: Exploring the interface with computational biology and AI
Ananya Ananya, Darshan C. Panchariya, Anandakrishnan Karthic, et al.
International Reviews of Immunology (2024) Vol. 43, Iss. 6, pp. 361-380
Closed Access | Times Cited: 9
Recent advances in the biosynthesis of polysaccharide-based antimicrobial glycoconjugate vaccines
Yuhui Wang, Huan Liu, Baoying Wang, et al.
Frontiers in Microbiology (2025) Vol. 15
Open Access | Times Cited: 2
Expanding the Potential of Circular RNA (CircRNA) Vaccines: A Promising Therapeutic Approach
Tian Bu, Wenlong Yang, Jian Zhao, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 379-379
Open Access | Times Cited: 1
Protection of Novel Adenovirus Vectored Vaccine in Rats Against Wild‐Type Hepacivirus and Variant Infections
Shengxue Luo, Qitao Deng, Chaolan Liang, et al.
Liver International (2025) Vol. 45, Iss. 4
Closed Access | Times Cited: 1
Engineered Cell Membrane‐Derived Nanoparticles in Immune Modulation
Yixiao Yang, Kai Wang, Yuanwei Pan, et al.
Advanced Science (2021) Vol. 8, Iss. 24
Open Access | Times Cited: 55
Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based Design
Daniel Ellis, Natalie Brunette, Katharine H. D. Crawford, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 47
SARS-CoV-2 infections elicit higher levels of original antigenic sin antibodies compared with SARS-CoV-2 mRNA vaccinations
Elizabeth M. Anderson, Shuk Hang Li, Moses Awofolaju, et al.
Cell Reports (2022) Vol. 41, Iss. 3, pp. 111496-111496
Open Access | Times Cited: 37
Mannose in vaccine delivery
Ummey Jannatun Nahar, István Tóth, Mariusz Skwarczyński
Journal of Controlled Release (2022) Vol. 351, pp. 284-300
Closed Access | Times Cited: 35
Mesenchymal stem cell-based treatments for COVID-19: status and future perspectives for clinical applications
Lijun Chen, Jingjing Qu, Farhin Shaheed Kalyani, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 3
Open Access | Times Cited: 33
Current progress in the development of prophylactic and therapeutic vaccines
Tingting Li, Ciying Qian, Ying Gu, et al.
Science China Life Sciences (2022) Vol. 66, Iss. 4, pp. 679-710
Open Access | Times Cited: 33
A Polyvalent Peptide CD40 Nanoagonist for Targeted Modulation of Dendritic Cells and Amplified Cancer Immunotherapy
Muhetaerjiang Mamuti, Yi Wang, Yongdan Zhao, et al.
Advanced Materials (2022) Vol. 34, Iss. 24
Closed Access | Times Cited: 32
Rational development of a combined mRNA vaccine against COVID-19 and influenza
Qing Ye, Mei Wu, Chao Zhou, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 32
Development of Nasal Vaccines and the Associated Challenges
Xuanxuan Nian, Jiayou Zhang, Shihe Huang, et al.
Pharmaceutics (2022) Vol. 14, Iss. 10, pp. 1983-1983
Open Access | Times Cited: 29
Autoimmune hepatitis after COVID-19 vaccination
Zheng Han, Ting Zhang, Yiyao Xu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 29
Host Responses to Respiratory Syncytial Virus Infection
Ayse Agac, Sophie M. Kolbe, Martin Ludlow, et al.
Viruses (2023) Vol. 15, Iss. 10, pp. 1999-1999
Open Access | Times Cited: 23
Bioengineered nanotechnology for nucleic acid delivery
Yang Zhang, Jing Luo, Xiran Gui, et al.
Journal of Controlled Release (2023) Vol. 364, pp. 124-141
Open Access | Times Cited: 22

Scroll to top